Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers

Iris A.S. Stroot(University Medical Center Groningen), Marian J E Mourits(University Medical Center Groningen), Refika Yigit(University Medical Center Groningen), Hebon Investigators(The Netherlands Cancer Institute), Mathilde Jalving(University Medical Center Groningen), Marc van Beurden(Oncode Institute), Ronald P. Zweemer(Cancer Genomics Centre), Peter Devilee(Leiden University), Geertruida H. de Bock(University Medical Center Groningen), Marise M. Wagner(University Medical Center Groningen), Marijke R. Wevers(Radboud University Nijmegen), Liselotte P. van Hest(Amsterdam University Medical Centers), Margreet G E M Ausems(University Medical Center Utrecht), Floor A.M. Duijkers(Amsterdam University of Applied Sciences), Helena C. van Doorn(Erasmus MC Cancer Institute), Katja N. Gaarenstroom(Leiden University Medical Center), Marjanka K. Schmidt(Leiden University Medical Center), Joost Bart(University Medical Center Groningen), Luc R.C.W. van Lonkhuijzen, Encarna B. Gómez García(Maastricht University), Ingrid A. Boere(Erasmus MC Cancer Institute), Christi J. van Asperen(Leiden University Medical Center), Marielle W.G. Ruijs(The Netherlands Cancer Institute), J. Margriet Collée(Erasmus MC Cancer Institute), B.F.M. Slangen(Maastricht University Medical Centre), Joanne A. de Hullu(Radboud University Nijmegen), Harry Hollema(University Medical Center Groningen)
Gynecologic Oncology
May 24, 2024
Cited by 2


Related Papers